Open AccessWhat are the first-line treatments for rheumatoid arthritis ?
Author(s) -
Assia Haddouche,
Samy Slimani,
B. Bengana,
I. Bencharif,
Abdelbaki Benmebarek
Publication year - 2014
Publication title -
batna journal of medical sciences
Language(s) - English
Resource type - Journals
ISSN - 2437-0665
DOI - 10.48087/bjmstf.2014.1108
Subject(s) - rheumatoid arthritis , rheumatism , medicine , methotrexate , antirheumatic drugs , antirheumatic agents , second line , disease , league , physical therapy , intensive care medicine , arthritis , first line , physics , astronomy
The management of rheumatoid arthritis has not stopped evolving after the advent of new effective therapies and the emergence of new concepts such as tight control, early and aggressive treatment with a target of remission, or at least low disease activity. Strategies to follow are now well codified by the new recommendations of the European League Against Rheumatism (EULAR) 2013, which clearly emphasized that conventional disease-modifying antirheumatic drugs (DMARDs) with methotrexate as a leader are the first-line therapies to use in the treatment of rheumatoid arthritis.